Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis
Status: Completed
Location: See all (7) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
PMCF study to observe the Routine application of Ostenil® Plus in the Treatment of pain and restricted mobility in degenerative and traumatic changes of the Hip Joint.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:
• Subjects ≥ 18 years of age and in good general health condition
• Signed informed consent
• Existing Ostenil® Plus recommendation for the treatment of coxarthrosis
Locations
Other Locations
Germany
Gemeinschaftspraxis für Orthopädie und Unfallchirurgie
Bad Oldesloe
Orthopädische Gemeinschaftspraxis Eutin
Eutin
Orthopraxis Kiel
Gettorf
Orthopädische Praxis Rahlstedt
Hamburg
Zentrum für Medizin des Bewegungsapparates
Heide
Orthopädie Praxis
Ramelsloh
OrthopädieZentrum Maschen
Seevetal
Time Frame
Start Date: 2019-02-15
Completion Date: 2025-05-14
Participants
Target number of participants: 170
Treatments
Ostenil® Plus
1-3 injections of sodium hyaluronate 2% (40 milligrams (mg) / 2,0 millilitres (ml)) in weekly interval.
Authors
Knut Behle
Related Therapeutic Areas
Sponsors
Leads: TRB Chemedica AG